IPO and Fundraising - The company completed its initial public offering on February 23, 2024, selling 6,900,000 units at $10.00 per unit, generating gross proceeds of $69,000,000[92]. - A private placement with DT Cloud Capital Corp. raised an additional $2,345,000 from the sale of 234,500 units at $10.00 per unit[92]. - As of February 23, 2024, a total of $69,345,000 from the IPO and private placement was deposited in a trust account for public shareholders[92]. - The company has a total of $69,345,000 in net proceeds from its initial public offering and private placement, which are intended for completing its initial business combination[107]. - The underwriters are entitled to a cash underwriting discount of 2.5% of the gross proceeds from the initial public offering, amounting to $1,725,000[116]. Business Combination - The company has a 12-month period from the IPO closing to complete its initial business combination, extendable to 24 months with additional funds deposited into the trust account[95]. - A definitive business combination agreement was entered into with Maius Pharmaceutical Co., Ltd. on October 22, 2024[97]. - The company entered into a Business Combination Agreement on October 22, 2024, which will result in becoming a wholly owned subsidiary of Pubco[119]. Financial Performance - For the three months ended September 30, 2024, the company reported a net income of $760,262, compared to a net loss of $5,000 for the same period in 2023[114]. - For the nine months ended September 30, 2024, the company achieved a net income of $1,633,003, significantly up from $5,257 in the same period of 2023[115]. - As of September 30, 2024, the company had cash at bank of $167,526 and cash used in operating activities was $671,186[109]. - The company will not generate operating revenues until the completion of its initial business combination, relying on non-operating income from interest earned on the trust account[113]. Risks and Challenges - The company is subject to risks from geopolitical instability and economic uncertainties affecting capital markets[104]. - The company may face challenges in finding a suitable business combination target due to negative impacts from global economic conditions[105]. Other Financial Obligations - The company issued an unsecured promissory note allowing borrowing up to $300,000, with a principal amount due of $0 as of September 30, 2024[110]. - The company has a temporary advance of $70,000 from the sponsor as of September 30, 2024, down from $490,000 at the end of 2023[111]. - The company has agreed to pay its sponsor $10,000 per month for administrative support services until the consummation of the initial business combination[117]. Trading Information - The company’s units began trading on Nasdaq under the ticker symbol "DYCQU" on February 21, 2024[93]. - The anticipated per-share amount for redemption is initially $10.05, subject to potential increases[94].
Dt Cloud Acquisition Corporation(DYCQU) - 2024 Q3 - Quarterly Report